Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Atherosclerosis. 2018 May;272:60-65. doi: 10.1016/j.atherosclerosis.2018.03.015. Epub 2018 Mar 8.
Increasing evidence shows that intracranial carotid artery atherosclerosis may develop under the influence of a differential metabolic risk factor profile than atherosclerosis in the extracranial part of the carotid artery. To further elucidate these differences, we investigated associations of a wide range of circulating metabolites with intracranial and extracranial carotid artery atherosclerosis.
From the population-based Rotterdam Study, blood samples from 1111 participants were used to determine a wide range of metabolites by proton nuclear magnetic resonance (NMR). Moreover, these participants underwent non-contrast computed tomography of the neck and head to quantify the amount of extra- and intracranial carotid artery calcification (ECAC and ICAC), as a proxy of atherosclerosis. We assessed associations of the metabolites with ICAC and ECAC and compared the metabolic association patterns of the two.
We found that one standard deviation (SD) increase in concentration of 3-hydroxybutyrate, a ketone body, was significantly associated with a 0.11 SD increase in ICAC volume (p = 1.8 × 10). When we compared the metabolic association pattern of ICAC with that of ECAC, we observed differences in glycolysis-related metabolite measures, lipoprotein subfractions, and amino acids. Interestingly, glycoprotein acetyls were associated with calcification in both studied vessel beds. These associations were most prominent in men.
We found that a higher circulating level of 3-hydroxybutyrate was associated with an increase in ICAC. Furthermore, we found differences in metabolic association patterns of ICAC and ECAC, providing further evidence for location-specific differences in the etiology of atherosclerosis.
越来越多的证据表明,颅内颈动脉粥样硬化的发生可能受到与颅外颈动脉粥样硬化不同的代谢风险因素谱的影响。为了进一步阐明这些差异,我们研究了广泛的循环代谢物与颅内和颅外颈动脉粥样硬化的相关性。
本研究来自于基于人群的鹿特丹研究,从 1111 名参与者中抽取血液样本,通过质子磁共振(NMR)来确定广泛的代谢物。此外,这些参与者还接受了颈部和头部的非对比计算机断层扫描,以量化颅外和颅内颈动脉钙化(ECAC 和 ICAC)的程度,作为粥样硬化的替代指标。我们评估了代谢物与 ICAC 和 ECAC 的相关性,并比较了两者的代谢相关性模式。
我们发现,酮体 3-羟基丁酸浓度增加一个标准差,与 ICAC 体积增加 0.11 个标准差显著相关(p=1.8×10)。当我们比较 ICAC 和 ECAC 的代谢相关性模式时,我们观察到与糖酵解相关的代谢物、脂蛋白亚组分和氨基酸的差异。有趣的是,糖蛋白乙酰基与两个研究血管床的钙化均相关。这些相关性在男性中最为明显。
我们发现,循环 3-羟基丁酸水平升高与 ICAC 增加有关。此外,我们发现 ICAC 和 ECAC 的代谢相关性模式存在差异,为动脉粥样硬化病因的特定部位差异提供了进一步证据。